Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
Clinical trial NCT03903640 · TERMINATED
Trial details
- NCT number
- NCT03903640
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-14
- Primary completion
- 2020-06-08
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.